KaloBios Pharmaceuticals, Inc. to Present at Needham Healthcare Conference  
4/25/2013 6:32:36 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., April 24, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company has been selected to present at the 12th Annual Needham Healthcare Conference, to be held in New York City on April 30-May 1, 2013. KaloBios Chief Financial Officer, Jeffrey H. Cooper, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.


Company Presentation:
When: Tuesday, April 30, 2013, 9:20 am EDT, Ambassador Presentation Room
Where: The Westin Grand Central Hotel, New York, NY

To access the live and archived audio webcast of the Needham Healthcare Conference presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab:

A replay of the webcast will be available one hour after the conclusion of the live event.

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer. For more information on KaloBios Pharmaceuticals, please visit our web site at


Jeffrey H. Cooper
Chief Financial Officer
KaloBios Pharmaceuticals, Inc.
(650) 243-3146

Media Contact:

Joan E. Kureczka
Kureczka/Martin Associates
Tel: (415) 821-2413
Mobile: (415) 690-0210

SOURCE KaloBios Pharmaceuticals, Inc.

Help employers find you! Check out all the jobs and post your resume.